Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapies use different ways to stimulate the immune system and stop
cancer cell from growing. Inserting genetic material made in the laboratory into a person's
blood cells may make the body build an immune response to kill tumor cells.
PURPOSE: Phase I trial to study the effectiveness of biological therapy and gene therapy in
treating children who have recurrent or refractory neuroblastoma.